Pharmaceutical Market Access and Drug Safety Act of 2005
Latest action · Mar 14, 2005 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedFeb 9, 2005
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Pharmaceutical Market Access and Drug Safety Act of 2005 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA) to revise provisions governing the importation of prescription drugs. Waives the limitation on importation of prescription drugs that have been exported from the United States.
Prohibits the importation of a qualifying drug unless such drug is imported by: (1) a registered importer; or (2) an individual for personal use.
Establishes registration conditions for importers and exporters. Requires the Secretary to inspect places of business, verify chains of custody, inspect facilities, and determine compliance with registration conditions.
Sets forth provisions governing the importation of qualifying drugs that are different from U.S. label drugs, including standards for judging such differences.
Prohibits manufacturers from: (1) discriminating against registered exporters or importers; (2) causing there to be a difference in a prescription drug distributed in the United States and one distributed in a permitted country; (3) engaging in actions to restrict, prohibit, or delay the importation of a qualifying drug; or (4) engaging in any action that the Federal Trade Commission (FTC) determines discriminates against a person that engages or attempts to engage in the importation of a qualifying drug.
States that the resale in the United States of prescription drugs that were properly sold abroad is not patent infringement.
Requires the Secretary to educate consumers regarding prescription drug importation.
Sets forth provisions governing the sale of prescription drugs through an Internet site. Includes the dispensing or selling of a prescription drug in violation of this Act as a prohibited act under FFDCA.
Cosponsors 22
Members who signed on, in the order they did. Signatures ran from Feb 9, 2005 to Oct 6, 2005; 7 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| R-KY | Anne M. Northup | Original | Feb 9, 2005 |
| I-VT | Bernard Sanders | Original | Feb 9, 2005 |
| D-KS | Dennis Moore | Original | Feb 9, 2005 |
| D-AR | Marion Berry | Original | Feb 9, 2005 |
| D-OH | Sherrod Brown | Original | Feb 9, 2005 |
| D-ME | Thomas H. Allen | Original | Feb 9, 2005 |
| R-TN | Zach Wamp | Original | Feb 9, 2005 |
| R-FL | Ginny Brown-Waite | Mar 16, 2005 | |
| D-TX | Gene Green | Apr 28, 2005 | |
| D-MI | Dale E. Kildee | May 3, 2005 | |
| D-MA | Barney Frank | May 5, 2005 | |
| D-CA | Bob Filner | May 5, 2005 | |
| D-OR | Peter A. DeFazio | May 5, 2005 | |
| D-FL | Robert Wexler | May 12, 2005 | |
| D-IL | Janice D. Schakowsky | May 18, 2005 | |
| D-CA | Lynn C. Woolsey | May 24, 2005 | |
| D-AZ | Raúl M. Grijalva | Jun 8, 2005 | |
| D-CA | Jim Costa | Sep 13, 2005 | |
| D-ME | Michael H. Michaud | Sep 13, 2005 | |
| D-KY | Ben Chandler | Oct 6, 2005 | |
| D-MD | C. A. Dutch Ruppersberger | Oct 6, 2005 | |
| D-MA | James P. McGovern | Oct 6, 2005 |
Committees 1
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Feb 9, 2005 |
| Health Subcommittee | Referred Mar 14, 2005 |
Actions 3
Everything that happened, newest first.
- Mar 14, 2005Referred to the Subcommittee on Health.
- Feb 9, 2005Introduced in House
- Feb 9, 2005Referred to the House Committee on Energy and Commerce.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
CRS reports 2
Congressional Research Service work that CRS links to this bill or the law it became, newest first.
Cite it 2
Products on other subjects that cite it, usually among other measures.
| Product | Title | Kind | Published |
|---|---|---|---|
| RS22660 | Prescription Drug Importation: How S. 1232 (S. 525/H.R. 1298) Would Change Current Law Archived | Report | Jun 16, 2009 |
| RL32511 | Importing Prescription Drugs: Objectives, Options, and Outlook Archived | Report | Jan 26, 2007 |
Related bills 1
Companion bills and other measures the record links to this one.
| Bill | Title | Relationship | Latest action |
|---|---|---|---|
| S 334 | Pharmaceutical Market Access and Drug Safety Act of 2005 | Identical bill | Apr 19, 2005 |
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend the Federal Food, Drug, and Cosmetic Act with respect to the importation of prescription drugs, and for other purposes.
- Short Titles as Introduced
- Pharmaceutical Market Access and Drug Safety Act of 2005
Subjects
Assigned by the Library of Congress. Policy area: Health.
- Accreditation (Medical care)
- Administrative fees
- Administrative procedure
- Administrative remedies
- Australia
- Business records
- Canada
- Civil actions and liability
- Civil Rights and Liberties, Minority Issues
- Commerce
- Congress
- Congressional reporting requirements
- Consumer education
- Contracts
- Crime and Law Enforcement
- Customs administration
- Damages
- Defective products
- Department of Health and Human Services
- Directories
- Drug advertising
- Drug approvals
- Drug industry
- Drugs
- East Asia
- Economics and Public Finance
- Education
- Electronic commerce
- Electronic data interchange
- Electronic government information
- Europe
- European Union
- Evidence (Law)
- Export controls
- Exports
- Federal Trade Commission
- Federal-state relations
- Finance and Financial Sector
- Fines (Penalties)
- Food and Drug Administration (FDA)
- Foreign Trade and International Finance
- Forfeiture
- Fraud
- Government Operations and Politics
- Government paperwork
- Government publicity
- Governmental investigations
- Health
- Higher education
- Identification devices
- Import restrictions
- Imports
- Independent regulatory commissions
- Injunctions
- Intellectual property
- Interactive media
- Internet
- Japan
- Labeling
- Law
- Liability (Law)
- Licenses
- Medical associations
- Medical education
- Medical records
- Medical tests
- New Zealand
- Oceania
- Packaging
- Parties to actions
- Patent infringement
- Patents
- Pharmaceutical research
- Pharmacies
- Pharmacists
- Physical examinations
- Prescription pricing
- Price discrimination
- Product counterfeiting
- Restrictive trade practices
- Right of privacy
- Science, Technology, Communications
- Surety and fidelity
- Switzerland
- Telephone
- User charges
- Web sites
- Wholesale trade
Text 1
Each version as it was printed, newest first.
- Feb 9, 2005Introduced in House
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.